The Children’s Tumor Foundation annual NF Conference is the most important yearly gathering of the NF research and clinical communities, all focused on improving outcomes for patients with neurofibromatosis type 1 (NF1), and all types of schwannomatosis (SWN), including NF2-related schwannomatosis (NF2-SWN) formerly referred to as neurofibromatosis type 2. The NF Conference is a global event, attracting participants worldwide across a wide range of scientific disciplines from research and clinical backgrounds. The event is a critical forum for consensus building and advancing basic, translational, and clinical research in NF and related fields, while fostering collaborations within and beyond the NF community.
Conferences & Education
The Children's Tumor Foundation is dedicated to continued discovery and education for NF healthcare professionals.
NF ConferenceNeurofibromatosis Young Investigators Forum
This December, we’re partnering with Creative Educational Concepts for the Neurofibromatosis Young Investigators’ Forum. This research forum aims to encourage, promote, and empower Young Investigators to forge collegial connections and acquire the necessary skills and relationships to increase their research productivity and catalyze their career trajectory in neurofibromatosis.
The abstract submission window has closed.
December 5-6, 2024
Renaissance Baltimore Harborplace Hotel
202 E Pratt St, Baltimore, MD 21202
Professional Education Series
INFER: Masterclasses in NF
INFER (International NF Educational Resources) is a series of online educational lectures for medical professionals by leading neurofibromatosis and schwannomatosis experts.
Learn More
Virtual Case Conferences
CTF’s Virtual Case Conferences are a monthly series organized by the Clinical Care Advisory Board on challenging issues in the management and treatment of NF1 and SWN, including NF2-SWN. Members of the NF Clinic Network are invited to attend the Virtual Case Conferences. For more information, please contact info@ctf.org.
Past Events & Workshops
- NF2 and Schwannomatosis Workshop 2022
- Diagnostic Criteria Revisions 2018
- Animal Model Workshop 2018
- Synodos Network Meeting 2017
NF2 and Schwannomatosis Workshop 2022
From Target to Drug to Clinic: On April 14, 2022, the Children’s Tumor Foundation hosted a full-day virtual workshop with expert clinicians, surgeons, researchers, and pharma representatives as we assess the current landscape of care, biology, and drug discovery for these rare disorders.
Diagnostic Criteria Revisions 2018
In June of 2018, The Children’s Tumor Foundation convened a group of 32 international experts in NYC at the Memorial Sloan Kettering Cancer Center to review and propose revisions to the diagnostic criteria of the neurofibromatoses, which had not been updated since NIH Consensus Conference in 1987. The goal of this workshop was to accurately and clearly delineate the conditions known at that time as NF1, NF2 and schwannomatosis, representing the best consensus among NF experts, to improve diagnostic accuracy. The final revisions were included by an expanded group of stakeholders, and incorporated input from patients, families and foundations, and other medical specialists, in addition to the original working group. The intent is for the new criteria to be usable, not just for NF specialists, but for all general practitioners.
To view the revised diagnostic criteria, Click Here
Animal Model Workshop 2018
In 2018, CTF hosted the second Neurofibromatosis Animal Model Workshop in Palm Springs, California. More than 20 animal models were presented at the United States and Canadian Academy of Pathology (USCAP) learning center and classified based on their histopathological features by expert pathologists. This was important for the validation of the models, for their analysis and comparison with other models, and for their future effective use in preclinical treatment trials.
Synodos Network Meeting 2017
In 2017, CTF organized a Synodos Network Meeting with all of the key leaders from all of the Synodos initiatives. The meeting provided a unique opportunity to share research updates and exchange views on specific Synodos-related matters and allowed essential input from CTF stakeholders, including patient representatives, donors, and board members.
Stay Up-To-Date
Join our mailing list for news, exclusive resources, events and opportunities.
"*" indicates required fields
